nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—Fingolimod—multiple sclerosis	0.0576	0.246	CbGbCtD
Olopatadine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0371	0.158	CbGbCtD
Olopatadine—S100B—peripheral nervous system—multiple sclerosis	0.0304	0.163	CbGeAlD
Olopatadine—CYP3A4—Triamcinolone—multiple sclerosis	0.0281	0.12	CbGbCtD
Olopatadine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0271	0.116	CbGbCtD
Olopatadine—CYP3A4—Betamethasone—multiple sclerosis	0.0241	0.103	CbGbCtD
Olopatadine—CYP3A4—Prednisolone—multiple sclerosis	0.0238	0.102	CbGbCtD
Olopatadine—S100B—nerve—multiple sclerosis	0.0237	0.127	CbGeAlD
Olopatadine—CYP3A4—Prednisone—multiple sclerosis	0.0225	0.0959	CbGbCtD
Olopatadine—CYP3A4—Dexamethasone—multiple sclerosis	0.014	0.0599	CbGbCtD
Olopatadine—S100A13—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0104	1	CbGdCrCtD
Olopatadine—S100B—brainstem—multiple sclerosis	0.0102	0.0547	CbGeAlD
Olopatadine—S100B—retina—multiple sclerosis	0.00982	0.0527	CbGeAlD
Olopatadine—S100A1—medulla oblongata—multiple sclerosis	0.00822	0.0441	CbGeAlD
Olopatadine—S100A1—midbrain—multiple sclerosis	0.00751	0.0403	CbGeAlD
Olopatadine—S100A1—spinal cord—multiple sclerosis	0.00733	0.0394	CbGeAlD
Olopatadine—S100B—midbrain—multiple sclerosis	0.00649	0.0348	CbGeAlD
Olopatadine—S100B—spinal cord—multiple sclerosis	0.00633	0.034	CbGeAlD
Olopatadine—S100A1—nervous system—multiple sclerosis	0.00617	0.0332	CbGeAlD
Olopatadine—S100A1—central nervous system—multiple sclerosis	0.00594	0.0319	CbGeAlD
Olopatadine—S100A1—cerebellum—multiple sclerosis	0.00581	0.0312	CbGeAlD
Olopatadine—S100A13—nervous system—multiple sclerosis	0.00548	0.0294	CbGeAlD
Olopatadine—S100B—nervous system—multiple sclerosis	0.00533	0.0286	CbGeAlD
Olopatadine—S100A13—central nervous system—multiple sclerosis	0.00527	0.0283	CbGeAlD
Olopatadine—S100A13—cerebellum—multiple sclerosis	0.00515	0.0277	CbGeAlD
Olopatadine—S100B—central nervous system—multiple sclerosis	0.00513	0.0276	CbGeAlD
Olopatadine—S100A2—brain—multiple sclerosis	0.00512	0.0275	CbGeAlD
Olopatadine—S100B—cerebellum—multiple sclerosis	0.00502	0.027	CbGeAlD
Olopatadine—S100A1—brain—multiple sclerosis	0.00472	0.0253	CbGeAlD
Olopatadine—S100A13—brain—multiple sclerosis	0.00419	0.0225	CbGeAlD
Olopatadine—S100A12—brain—multiple sclerosis	0.00413	0.0222	CbGeAlD
Olopatadine—S100B—brain—multiple sclerosis	0.00408	0.0219	CbGeAlD
Olopatadine—HRH1—nervous system—multiple sclerosis	0.00109	0.00587	CbGeAlD
Olopatadine—HRH1—central nervous system—multiple sclerosis	0.00105	0.00566	CbGeAlD
Olopatadine—CYP3A4—nervous system—multiple sclerosis	0.000846	0.00454	CbGeAlD
Olopatadine—HRH1—brain—multiple sclerosis	0.000836	0.00449	CbGeAlD
Olopatadine—CYP3A4—central nervous system—multiple sclerosis	0.000814	0.00437	CbGeAlD
Olopatadine—Body temperature increased—Cladribine—multiple sclerosis	0.000755	0.00239	CcSEcCtD
Olopatadine—Skin disorder—Azathioprine—multiple sclerosis	0.000754	0.00239	CcSEcCtD
Olopatadine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000753	0.00239	CcSEcCtD
Olopatadine—Back pain—Mitoxantrone—multiple sclerosis	0.000744	0.00236	CcSEcCtD
Olopatadine—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000741	0.00235	CcSEcCtD
Olopatadine—Infestation—Methylprednisolone—multiple sclerosis	0.000741	0.00235	CcSEcCtD
Olopatadine—Vision blurred—Mitoxantrone—multiple sclerosis	0.000725	0.0023	CcSEcCtD
Olopatadine—Conjunctivitis—Triamcinolone—multiple sclerosis	0.000722	0.00229	CcSEcCtD
Olopatadine—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000713	0.00226	CcSEcCtD
Olopatadine—Hypersensitivity—Cladribine—multiple sclerosis	0.000703	0.00223	CcSEcCtD
Olopatadine—Epistaxis—Triamcinolone—multiple sclerosis	0.0007	0.00222	CcSEcCtD
Olopatadine—Visual impairment—Prednisolone—multiple sclerosis	0.000698	0.00221	CcSEcCtD
Olopatadine—Dry skin—Prednisone—multiple sclerosis	0.000698	0.00221	CcSEcCtD
Olopatadine—Malaise—Mitoxantrone—multiple sclerosis	0.000693	0.0022	CcSEcCtD
Olopatadine—Weight increased—Dexamethasone—multiple sclerosis	0.000687	0.00218	CcSEcCtD
Olopatadine—Weight increased—Betamethasone—multiple sclerosis	0.000687	0.00218	CcSEcCtD
Olopatadine—Asthenia—Cladribine—multiple sclerosis	0.000685	0.00217	CcSEcCtD
Olopatadine—Pruritus—Cladribine—multiple sclerosis	0.000675	0.00214	CcSEcCtD
Olopatadine—Visual disturbance—Methotrexate—multiple sclerosis	0.000671	0.00213	CcSEcCtD
Olopatadine—Cough—Mitoxantrone—multiple sclerosis	0.000671	0.00213	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00067	0.00212	CcSEcCtD
Olopatadine—Rhinitis—Triamcinolone—multiple sclerosis	0.000668	0.00212	CcSEcCtD
Olopatadine—Rhinitis—Methylprednisolone—multiple sclerosis	0.000667	0.00211	CcSEcCtD
Olopatadine—Pharyngitis—Triamcinolone—multiple sclerosis	0.000661	0.0021	CcSEcCtD
Olopatadine—Conjunctivitis—Dexamethasone—multiple sclerosis	0.000655	0.00207	CcSEcCtD
Olopatadine—Conjunctivitis—Betamethasone—multiple sclerosis	0.000655	0.00207	CcSEcCtD
Olopatadine—Diarrhoea—Cladribine—multiple sclerosis	0.000653	0.00207	CcSEcCtD
Olopatadine—Discomfort—Mitoxantrone—multiple sclerosis	0.000647	0.00205	CcSEcCtD
Olopatadine—Visual impairment—Methylprednisolone—multiple sclerosis	0.000641	0.00203	CcSEcCtD
Olopatadine—Feeling abnormal—Azathioprine—multiple sclerosis	0.00064	0.00203	CcSEcCtD
Olopatadine—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000635	0.00201	CcSEcCtD
Olopatadine—Dizziness—Cladribine—multiple sclerosis	0.000631	0.002	CcSEcCtD
Olopatadine—Erythema—Prednisolone—multiple sclerosis	0.000631	0.002	CcSEcCtD
Olopatadine—Oedema—Mitoxantrone—multiple sclerosis	0.000628	0.00199	CcSEcCtD
Olopatadine—Infection—Mitoxantrone—multiple sclerosis	0.000623	0.00197	CcSEcCtD
Olopatadine—Eye disorder—Methylprednisolone—multiple sclerosis	0.000621	0.00197	CcSEcCtD
Olopatadine—Body temperature increased—Azathioprine—multiple sclerosis	0.000614	0.00194	CcSEcCtD
Olopatadine—Abdominal pain—Azathioprine—multiple sclerosis	0.000614	0.00194	CcSEcCtD
Olopatadine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00061	0.00193	CcSEcCtD
Olopatadine—Vomiting—Cladribine—multiple sclerosis	0.000607	0.00192	CcSEcCtD
Olopatadine—Rash—Cladribine—multiple sclerosis	0.000602	0.00191	CcSEcCtD
Olopatadine—Dermatitis—Cladribine—multiple sclerosis	0.000601	0.00191	CcSEcCtD
Olopatadine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000601	0.0019	CcSEcCtD
Olopatadine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000599	0.0019	CcSEcCtD
Olopatadine—Weight increased—Prednisone—multiple sclerosis	0.000599	0.0019	CcSEcCtD
Olopatadine—Headache—Cladribine—multiple sclerosis	0.000598	0.00189	CcSEcCtD
Olopatadine—Vision blurred—Prednisolone—multiple sclerosis	0.000595	0.00188	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000585	0.00185	CcSEcCtD
Olopatadine—Depression—Prednisone—multiple sclerosis	0.000585	0.00185	CcSEcCtD
Olopatadine—Visual impairment—Dexamethasone—multiple sclerosis	0.000583	0.00185	CcSEcCtD
Olopatadine—Visual impairment—Betamethasone—multiple sclerosis	0.000583	0.00185	CcSEcCtD
Olopatadine—Erythema—Triamcinolone—multiple sclerosis	0.00058	0.00184	CcSEcCtD
Olopatadine—Erythema—Methylprednisolone—multiple sclerosis	0.000579	0.00183	CcSEcCtD
Olopatadine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000572	0.00181	CcSEcCtD
Olopatadine—Malaise—Prednisolone—multiple sclerosis	0.000569	0.0018	CcSEcCtD
Olopatadine—Dysgeusia—Triamcinolone—multiple sclerosis	0.000568	0.0018	CcSEcCtD
Olopatadine—Nausea—Cladribine—multiple sclerosis	0.000567	0.0018	CcSEcCtD
Olopatadine—Eye disorder—Betamethasone—multiple sclerosis	0.000565	0.00179	CcSEcCtD
Olopatadine—Eye disorder—Dexamethasone—multiple sclerosis	0.000565	0.00179	CcSEcCtD
Olopatadine—Back pain—Triamcinolone—multiple sclerosis	0.000561	0.00178	CcSEcCtD
Olopatadine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000559	0.00177	CcSEcCtD
Olopatadine—Somnolence—Mitoxantrone—multiple sclerosis	0.000558	0.00177	CcSEcCtD
Olopatadine—Fatigue—Mitoxantrone—multiple sclerosis	0.000541	0.00171	CcSEcCtD
Olopatadine—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000538	0.00171	CcSEcCtD
Olopatadine—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000537	0.0017	CcSEcCtD
Olopatadine—Pain—Mitoxantrone—multiple sclerosis	0.000537	0.0017	CcSEcCtD
Olopatadine—Diarrhoea—Azathioprine—multiple sclerosis	0.000531	0.00168	CcSEcCtD
Olopatadine—Discomfort—Prednisolone—multiple sclerosis	0.000531	0.00168	CcSEcCtD
Olopatadine—Erythema—Betamethasone—multiple sclerosis	0.000526	0.00167	CcSEcCtD
Olopatadine—Erythema—Dexamethasone—multiple sclerosis	0.000526	0.00167	CcSEcCtD
Olopatadine—Malaise—Triamcinolone—multiple sclerosis	0.000523	0.00166	CcSEcCtD
Olopatadine—Malaise—Methylprednisolone—multiple sclerosis	0.000522	0.00165	CcSEcCtD
Olopatadine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000517	0.00164	CcSEcCtD
Olopatadine—Oedema—Prednisolone—multiple sclerosis	0.000515	0.00163	CcSEcCtD
Olopatadine—Dizziness—Azathioprine—multiple sclerosis	0.000513	0.00163	CcSEcCtD
Olopatadine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000513	0.00163	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000511	0.00162	CcSEcCtD
Olopatadine—Cough—Triamcinolone—multiple sclerosis	0.000506	0.0016	CcSEcCtD
Olopatadine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000496	0.00157	CcSEcCtD
Olopatadine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000496	0.00157	CcSEcCtD
Olopatadine—Vomiting—Azathioprine—multiple sclerosis	0.000494	0.00156	CcSEcCtD
Olopatadine—Eye disorder—Prednisone—multiple sclerosis	0.000492	0.00156	CcSEcCtD
Olopatadine—Infestation NOS—Methotrexate—multiple sclerosis	0.00049	0.00155	CcSEcCtD
Olopatadine—Infestation—Methotrexate—multiple sclerosis	0.00049	0.00155	CcSEcCtD
Olopatadine—Rash—Azathioprine—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Olopatadine—Dermatitis—Azathioprine—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Olopatadine—Depression—Methotrexate—multiple sclerosis	0.000489	0.00155	CcSEcCtD
Olopatadine—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000488	0.00155	CcSEcCtD
Olopatadine—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000488	0.00155	CcSEcCtD
Olopatadine—Discomfort—Triamcinolone—multiple sclerosis	0.000488	0.00155	CcSEcCtD
Olopatadine—Discomfort—Methylprednisolone—multiple sclerosis	0.000487	0.00154	CcSEcCtD
Olopatadine—Headache—Azathioprine—multiple sclerosis	0.000486	0.00154	CcSEcCtD
Olopatadine—Dry mouth—Triamcinolone—multiple sclerosis	0.000483	0.00153	CcSEcCtD
Olopatadine—Conjunctivitis—Methotrexate—multiple sclerosis	0.000477	0.00151	CcSEcCtD
Olopatadine—Immune system disorder—Prednisone—multiple sclerosis	0.000476	0.00151	CcSEcCtD
Olopatadine—Malaise—Dexamethasone—multiple sclerosis	0.000475	0.0015	CcSEcCtD
Olopatadine—Malaise—Betamethasone—multiple sclerosis	0.000475	0.0015	CcSEcCtD
Olopatadine—Oedema—Triamcinolone—multiple sclerosis	0.000473	0.0015	CcSEcCtD
Olopatadine—Infection—Triamcinolone—multiple sclerosis	0.00047	0.00149	CcSEcCtD
Olopatadine—Infection—Methylprednisolone—multiple sclerosis	0.000469	0.00149	CcSEcCtD
Olopatadine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000463	0.00147	CcSEcCtD
Olopatadine—Epistaxis—Methotrexate—multiple sclerosis	0.000462	0.00146	CcSEcCtD
Olopatadine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000462	0.00146	CcSEcCtD
Olopatadine—Nausea—Azathioprine—multiple sclerosis	0.000461	0.00146	CcSEcCtD
Olopatadine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000459	0.00145	CcSEcCtD
Olopatadine—Erythema—Prednisone—multiple sclerosis	0.000458	0.00145	CcSEcCtD
Olopatadine—Asthenia—Mitoxantrone—multiple sclerosis	0.00045	0.00143	CcSEcCtD
Olopatadine—Discomfort—Dexamethasone—multiple sclerosis	0.000443	0.0014	CcSEcCtD
Olopatadine—Discomfort—Betamethasone—multiple sclerosis	0.000443	0.0014	CcSEcCtD
Olopatadine—Pain—Prednisolone—multiple sclerosis	0.00044	0.00139	CcSEcCtD
Olopatadine—Pharyngitis—Methotrexate—multiple sclerosis	0.000437	0.00138	CcSEcCtD
Olopatadine—Vision blurred—Prednisone—multiple sclerosis	0.000432	0.00137	CcSEcCtD
Olopatadine—Oedema—Betamethasone—multiple sclerosis	0.00043	0.00136	CcSEcCtD
Olopatadine—Oedema—Dexamethasone—multiple sclerosis	0.00043	0.00136	CcSEcCtD
Olopatadine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000429	0.00136	CcSEcCtD
Olopatadine—Infection—Dexamethasone—multiple sclerosis	0.000427	0.00135	CcSEcCtD
Olopatadine—Infection—Betamethasone—multiple sclerosis	0.000427	0.00135	CcSEcCtD
Olopatadine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000425	0.00135	CcSEcCtD
Olopatadine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000424	0.00134	CcSEcCtD
Olopatadine—Visual impairment—Methotrexate—multiple sclerosis	0.000424	0.00134	CcSEcCtD
Olopatadine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000422	0.00134	CcSEcCtD
Olopatadine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000421	0.00133	CcSEcCtD
Olopatadine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000421	0.00133	CcSEcCtD
Olopatadine—Malaise—Prednisone—multiple sclerosis	0.000413	0.00131	CcSEcCtD
Olopatadine—Eye disorder—Methotrexate—multiple sclerosis	0.000411	0.0013	CcSEcCtD
Olopatadine—Fatigue—Triamcinolone—multiple sclerosis	0.000408	0.00129	CcSEcCtD
Olopatadine—Fatigue—Methylprednisolone—multiple sclerosis	0.000407	0.00129	CcSEcCtD
Olopatadine—Pain—Triamcinolone—multiple sclerosis	0.000405	0.00128	CcSEcCtD
Olopatadine—Vomiting—Mitoxantrone—multiple sclerosis	0.000399	0.00126	CcSEcCtD
Olopatadine—Immune system disorder—Methotrexate—multiple sclerosis	0.000397	0.00126	CcSEcCtD
Olopatadine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000397	0.00126	CcSEcCtD
Olopatadine—Rash—Mitoxantrone—multiple sclerosis	0.000396	0.00125	CcSEcCtD
Olopatadine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000395	0.00125	CcSEcCtD
Olopatadine—Headache—Mitoxantrone—multiple sclerosis	0.000393	0.00125	CcSEcCtD
Olopatadine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00039	0.00124	CcSEcCtD
Olopatadine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000389	0.00123	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000388	0.00123	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000386	0.00122	CcSEcCtD
Olopatadine—Discomfort—Prednisone—multiple sclerosis	0.000386	0.00122	CcSEcCtD
Olopatadine—Erythema—Methotrexate—multiple sclerosis	0.000383	0.00121	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000379	0.0012	CcSEcCtD
Olopatadine—Dysgeusia—Methotrexate—multiple sclerosis	0.000375	0.00119	CcSEcCtD
Olopatadine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000374	0.00119	CcSEcCtD
Olopatadine—Oedema—Prednisone—multiple sclerosis	0.000374	0.00119	CcSEcCtD
Olopatadine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000373	0.00118	CcSEcCtD
Olopatadine—Nausea—Mitoxantrone—multiple sclerosis	0.000373	0.00118	CcSEcCtD
Olopatadine—Infection—Prednisone—multiple sclerosis	0.000372	0.00118	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000371	0.00117	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000371	0.00117	CcSEcCtD
Olopatadine—Back pain—Methotrexate—multiple sclerosis	0.000371	0.00117	CcSEcCtD
Olopatadine—Fatigue—Dexamethasone—multiple sclerosis	0.00037	0.00117	CcSEcCtD
Olopatadine—Fatigue—Betamethasone—multiple sclerosis	0.00037	0.00117	CcSEcCtD
Olopatadine—Pain—Dexamethasone—multiple sclerosis	0.000367	0.00116	CcSEcCtD
Olopatadine—Pain—Betamethasone—multiple sclerosis	0.000367	0.00116	CcSEcCtD
Olopatadine—Nervous system disorder—Prednisone—multiple sclerosis	0.000367	0.00116	CcSEcCtD
Olopatadine—Skin disorder—Prednisone—multiple sclerosis	0.000363	0.00115	CcSEcCtD
Olopatadine—Vision blurred—Methotrexate—multiple sclerosis	0.000361	0.00114	CcSEcCtD
Olopatadine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000355	0.00113	CcSEcCtD
Olopatadine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000354	0.00112	CcSEcCtD
Olopatadine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000354	0.00112	CcSEcCtD
Olopatadine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000351	0.00111	CcSEcCtD
Olopatadine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000351	0.00111	CcSEcCtD
Olopatadine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000349	0.0011	CcSEcCtD
Olopatadine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000348	0.0011	CcSEcCtD
Olopatadine—Malaise—Methotrexate—multiple sclerosis	0.000345	0.00109	CcSEcCtD
Olopatadine—S100B—Signaling by ERBB4—MAPK1—multiple sclerosis	0.000345	0.00136	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000344	0.00136	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRA—multiple sclerosis	0.000343	0.00135	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NOD1—multiple sclerosis	0.000342	0.00135	CbGpPWpGaD
Olopatadine—Dizziness—Prednisolone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Asthenia—Triamcinolone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Body temperature increased—Betamethasone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Body temperature increased—Dexamethasone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Abdominal pain—Dexamethasone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Abdominal pain—Betamethasone—multiple sclerosis	0.00034	0.00108	CcSEcCtD
Olopatadine—Asthenia—Methylprednisolone—multiple sclerosis	0.000339	0.00107	CcSEcCtD
Olopatadine—S100B—Activated TLR4 signalling—IL6—multiple sclerosis	0.000336	0.00133	CbGpPWpGaD
Olopatadine—Pruritus—Triamcinolone—multiple sclerosis	0.000335	0.00106	CcSEcCtD
Olopatadine—S100A12—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000334	0.00132	CbGpPWpGaD
Olopatadine—Cough—Methotrexate—multiple sclerosis	0.000334	0.00106	CcSEcCtD
Olopatadine—Pruritus—Methylprednisolone—multiple sclerosis	0.000334	0.00106	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—S1PR1—multiple sclerosis	0.00033	0.00131	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MALT1—multiple sclerosis	0.00033	0.0013	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IRF5—multiple sclerosis	0.000325	0.00128	CbGpPWpGaD
Olopatadine—Rash—Prednisolone—multiple sclerosis	0.000325	0.00103	CcSEcCtD
Olopatadine—Dermatitis—Prednisolone—multiple sclerosis	0.000324	0.00103	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000324	0.00103	CcSEcCtD
Olopatadine—S100B—Immune System—NOD1—multiple sclerosis	0.000323	0.00128	CbGpPWpGaD
Olopatadine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000323	0.00102	CcSEcCtD
Olopatadine—Fatigue—Prednisone—multiple sclerosis	0.000323	0.00102	CcSEcCtD
Olopatadine—Headache—Prednisolone—multiple sclerosis	0.000323	0.00102	CcSEcCtD
Olopatadine—Discomfort—Methotrexate—multiple sclerosis	0.000322	0.00102	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000322	0.00127	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GPC5—multiple sclerosis	0.000321	0.00127	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD86—multiple sclerosis	0.00032	0.00127	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000319	0.00126	CbGpPWpGaD
Olopatadine—S100B—Toll Like Receptor 4 (TLR4) Cascade—IL6—multiple sclerosis	0.000316	0.00125	CbGpPWpGaD
Olopatadine—Dizziness—Triamcinolone—multiple sclerosis	0.000313	0.000992	CcSEcCtD
Olopatadine—Dizziness—Methylprednisolone—multiple sclerosis	0.000312	0.00099	CcSEcCtD
Olopatadine—S100B—Immune System—MALT1—multiple sclerosis	0.000312	0.00123	CbGpPWpGaD
Olopatadine—Infection—Methotrexate—multiple sclerosis	0.000311	0.000984	CcSEcCtD
Olopatadine—S100A12—Immune System—IRF8—multiple sclerosis	0.00031	0.00123	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFIH1—multiple sclerosis	0.00031	0.00123	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-G—multiple sclerosis	0.00031	0.00123	CbGpPWpGaD
Olopatadine—Feeling abnormal—Prednisone—multiple sclerosis	0.000308	0.000977	CcSEcCtD
Olopatadine—Asthenia—Dexamethasone—multiple sclerosis	0.000308	0.000976	CcSEcCtD
Olopatadine—Asthenia—Betamethasone—multiple sclerosis	0.000308	0.000976	CcSEcCtD
Olopatadine—S100B—Immune System—IRF5—multiple sclerosis	0.000307	0.00121	CbGpPWpGaD
Olopatadine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000307	0.000971	CcSEcCtD
Olopatadine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000306	0.000969	CcSEcCtD
Olopatadine—Nausea—Prednisolone—multiple sclerosis	0.000306	0.000969	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—S1PR1—multiple sclerosis	0.000304	0.0012	CbGpPWpGaD
Olopatadine—Pruritus—Betamethasone—multiple sclerosis	0.000304	0.000963	CcSEcCtD
Olopatadine—Pruritus—Dexamethasone—multiple sclerosis	0.000304	0.000963	CcSEcCtD
Olopatadine—Skin disorder—Methotrexate—multiple sclerosis	0.000304	0.000962	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CD86—multiple sclerosis	0.000303	0.0012	CbGpPWpGaD
Olopatadine—Vomiting—Triamcinolone—multiple sclerosis	0.000301	0.000954	CcSEcCtD
Olopatadine—Vomiting—Methylprednisolone—multiple sclerosis	0.0003	0.000951	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—HLA-B—multiple sclerosis	0.000299	0.00118	CbGpPWpGaD
Olopatadine—Rash—Triamcinolone—multiple sclerosis	0.000299	0.000946	CcSEcCtD
Olopatadine—Dermatitis—Triamcinolone—multiple sclerosis	0.000298	0.000945	CcSEcCtD
Olopatadine—Rash—Methylprednisolone—multiple sclerosis	0.000298	0.000944	CcSEcCtD
Olopatadine—S100A12—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000298	0.00118	CbGpPWpGaD
Olopatadine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000298	0.000943	CcSEcCtD
Olopatadine—Headache—Triamcinolone—multiple sclerosis	0.000297	0.00094	CcSEcCtD
Olopatadine—Headache—Methylprednisolone—multiple sclerosis	0.000296	0.000937	CcSEcCtD
Olopatadine—Body temperature increased—Prednisone—multiple sclerosis	0.000296	0.000937	CcSEcCtD
Olopatadine—Abdominal pain—Prednisone—multiple sclerosis	0.000296	0.000937	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000295	0.00116	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000295	0.00116	CbGpPWpGaD
Olopatadine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000294	0.000931	CcSEcCtD
Olopatadine—Diarrhoea—Betamethasone—multiple sclerosis	0.000294	0.000931	CcSEcCtD
Olopatadine—S100B—Immune System—IRF8—multiple sclerosis	0.000294	0.00116	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFIH1—multiple sclerosis	0.000294	0.00116	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-G—multiple sclerosis	0.000294	0.00116	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TNFAIP3—multiple sclerosis	0.000291	0.00115	CbGpPWpGaD
Olopatadine—Dizziness—Betamethasone—multiple sclerosis	0.000284	0.0009	CcSEcCtD
Olopatadine—Dizziness—Dexamethasone—multiple sclerosis	0.000284	0.0009	CcSEcCtD
Olopatadine—S100B—Innate Immune System—HLA-B—multiple sclerosis	0.000283	0.00112	CbGpPWpGaD
Olopatadine—S100B—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000282	0.00111	CbGpPWpGaD
Olopatadine—Nausea—Triamcinolone—multiple sclerosis	0.000281	0.000891	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—RGS1—multiple sclerosis	0.000281	0.00111	CbGpPWpGaD
Olopatadine—Nausea—Methylprednisolone—multiple sclerosis	0.000281	0.000889	CcSEcCtD
Olopatadine—Dyspnoea—Methotrexate—multiple sclerosis	0.000279	0.000883	CcSEcCtD
Olopatadine—Somnolence—Methotrexate—multiple sclerosis	0.000278	0.00088	CcSEcCtD
Olopatadine—Hypersensitivity—Prednisone—multiple sclerosis	0.000276	0.000873	CcSEcCtD
Olopatadine—S100B—Immune System—TNFAIP3—multiple sclerosis	0.000275	0.00109	CbGpPWpGaD
Olopatadine—Vomiting—Betamethasone—multiple sclerosis	0.000273	0.000865	CcSEcCtD
Olopatadine—Vomiting—Dexamethasone—multiple sclerosis	0.000273	0.000865	CcSEcCtD
Olopatadine—Rash—Betamethasone—multiple sclerosis	0.000271	0.000858	CcSEcCtD
Olopatadine—Rash—Dexamethasone—multiple sclerosis	0.000271	0.000858	CcSEcCtD
Olopatadine—Dermatitis—Betamethasone—multiple sclerosis	0.000271	0.000857	CcSEcCtD
Olopatadine—Dermatitis—Dexamethasone—multiple sclerosis	0.000271	0.000857	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00027	0.000855	CcSEcCtD
Olopatadine—Fatigue—Methotrexate—multiple sclerosis	0.00027	0.000854	CcSEcCtD
Olopatadine—Headache—Betamethasone—multiple sclerosis	0.000269	0.000852	CcSEcCtD
Olopatadine—Headache—Dexamethasone—multiple sclerosis	0.000269	0.000852	CcSEcCtD
Olopatadine—Asthenia—Prednisone—multiple sclerosis	0.000268	0.00085	CcSEcCtD
Olopatadine—Pain—Methotrexate—multiple sclerosis	0.000267	0.000847	CcSEcCtD
Olopatadine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000267	0.00105	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000267	0.00105	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GPR65—multiple sclerosis	0.000266	0.00105	CbGpPWpGaD
Olopatadine—S100B—Signaling by ERBB4—IL6—multiple sclerosis	0.000265	0.00105	CbGpPWpGaD
Olopatadine—Pruritus—Prednisone—multiple sclerosis	0.000265	0.000838	CcSEcCtD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000263	0.00104	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000263	0.00104	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD28—multiple sclerosis	0.000261	0.00103	CbGpPWpGaD
Olopatadine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000258	0.000816	CcSEcCtD
Olopatadine—S100A12—Immune System—PTPRC—multiple sclerosis	0.000257	0.00101	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CCR2—multiple sclerosis	0.000257	0.00101	CbGpPWpGaD
Olopatadine—Diarrhoea—Prednisone—multiple sclerosis	0.000256	0.000811	CcSEcCtD
Olopatadine—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000256	0.00081	CcSEcCtD
Olopatadine—Nausea—Dexamethasone—multiple sclerosis	0.000255	0.000808	CcSEcCtD
Olopatadine—Nausea—Betamethasone—multiple sclerosis	0.000255	0.000808	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TLR4—multiple sclerosis	0.000253	0.001	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DPB1—multiple sclerosis	0.000248	0.00098	CbGpPWpGaD
Olopatadine—Dizziness—Prednisone—multiple sclerosis	0.000247	0.000784	CcSEcCtD
Olopatadine—S100B—Immune System—CD28—multiple sclerosis	0.000247	0.000977	CbGpPWpGaD
Olopatadine—Abdominal pain—Methotrexate—multiple sclerosis	0.000247	0.000783	CcSEcCtD
Olopatadine—Body temperature increased—Methotrexate—multiple sclerosis	0.000247	0.000783	CcSEcCtD
Olopatadine—HRH1—GPCR ligand binding—GPR65—multiple sclerosis	0.000245	0.000969	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR1—multiple sclerosis	0.000244	0.000962	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL13—multiple sclerosis	0.000244	0.000962	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTPRC—multiple sclerosis	0.000243	0.000959	CbGpPWpGaD
Olopatadine—S100B—Immune System—CCR2—multiple sclerosis	0.000243	0.000959	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—STAT3—multiple sclerosis	0.000243	0.000959	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TLR4—multiple sclerosis	0.000239	0.000946	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ITGA4—multiple sclerosis	0.000239	0.000943	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40—multiple sclerosis	0.000239	0.000943	CbGpPWpGaD
Olopatadine—Vomiting—Prednisone—multiple sclerosis	0.000238	0.000753	CcSEcCtD
Olopatadine—S100A12—Immune System—IFNB1—multiple sclerosis	0.000237	0.000936	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000236	0.000932	CbGpPWpGaD
Olopatadine—Rash—Prednisone—multiple sclerosis	0.000236	0.000747	CcSEcCtD
Olopatadine—Dermatitis—Prednisone—multiple sclerosis	0.000236	0.000747	CcSEcCtD
Olopatadine—S100A12—Immune System—CTLA4—multiple sclerosis	0.000235	0.000929	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DPB1—multiple sclerosis	0.000235	0.000927	CbGpPWpGaD
Olopatadine—Headache—Prednisone—multiple sclerosis	0.000234	0.000742	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—CD80—multiple sclerosis	0.000234	0.000923	CbGpPWpGaD
Olopatadine—Hypersensitivity—Methotrexate—multiple sclerosis	0.00023	0.00073	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000228	0.0009	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40—multiple sclerosis	0.000226	0.000892	CbGpPWpGaD
Olopatadine—S100B—Immune System—ITGA4—multiple sclerosis	0.000226	0.000892	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000224	0.000887	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR1—multiple sclerosis	0.000224	0.000887	CbGpPWpGaD
Olopatadine—Asthenia—Methotrexate—multiple sclerosis	0.000224	0.000711	CcSEcCtD
Olopatadine—S100B—Immune System—IFNB1—multiple sclerosis	0.000224	0.000885	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTLA4—multiple sclerosis	0.000222	0.000879	CbGpPWpGaD
Olopatadine—Nausea—Prednisone—multiple sclerosis	0.000222	0.000704	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000222	0.000876	CbGpPWpGaD
Olopatadine—Pruritus—Methotrexate—multiple sclerosis	0.000221	0.000701	CcSEcCtD
Olopatadine—S100B—Innate Immune System—CD80—multiple sclerosis	0.000221	0.000873	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.000221	0.000872	CbGpPWpGaD
Olopatadine—Diarrhoea—Methotrexate—multiple sclerosis	0.000214	0.000678	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00021	0.00083	CbGpPWpGaD
Olopatadine—S100A12—Immune System—VCAM1—multiple sclerosis	0.000208	0.00082	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQA1—multiple sclerosis	0.000207	0.000818	CbGpPWpGaD
Olopatadine—Dizziness—Methotrexate—multiple sclerosis	0.000207	0.000655	CcSEcCtD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.000205	0.000808	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000202	0.000799	CbGpPWpGaD
Olopatadine—Vomiting—Methotrexate—multiple sclerosis	0.000199	0.00063	CcSEcCtD
Olopatadine—S100A12—Innate Immune System—TYK2—multiple sclerosis	0.000197	0.000779	CbGpPWpGaD
Olopatadine—Rash—Methotrexate—multiple sclerosis	0.000197	0.000624	CcSEcCtD
Olopatadine—Dermatitis—Methotrexate—multiple sclerosis	0.000197	0.000624	CcSEcCtD
Olopatadine—S100B—Immune System—VCAM1—multiple sclerosis	0.000196	0.000776	CbGpPWpGaD
Olopatadine—Headache—Methotrexate—multiple sclerosis	0.000196	0.00062	CcSEcCtD
Olopatadine—S100B—Immune System—HLA-DQA1—multiple sclerosis	0.000196	0.000774	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000195	0.000771	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DQB1—multiple sclerosis	0.000194	0.000765	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00019	0.00075	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD86—multiple sclerosis	0.000187	0.000737	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—TYK2—multiple sclerosis	0.000187	0.000737	CbGpPWpGaD
Olopatadine—Nausea—Methotrexate—multiple sclerosis	0.000186	0.000588	CcSEcCtD
Olopatadine—S100B—Immune System—HLA-DQB1—multiple sclerosis	0.000183	0.000724	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD40LG—multiple sclerosis	0.000183	0.000723	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD8A—multiple sclerosis	0.000181	0.000715	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CD4—multiple sclerosis	0.000178	0.000705	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD86—multiple sclerosis	0.000176	0.000697	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.000175	0.000692	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-B—multiple sclerosis	0.000174	0.000687	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL3—multiple sclerosis	0.000174	0.000686	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD40LG—multiple sclerosis	0.000173	0.000683	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000172	0.00068	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD8A—multiple sclerosis	0.000171	0.000676	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CD4—multiple sclerosis	0.000169	0.000666	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTGER4—multiple sclerosis	0.000167	0.00066	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-B—multiple sclerosis	0.000165	0.00065	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PGR—multiple sclerosis	0.000165	0.00065	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2RA—multiple sclerosis	0.000163	0.000644	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCR3—multiple sclerosis	0.000161	0.000638	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-A—multiple sclerosis	0.000161	0.000637	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL3—multiple sclerosis	0.00016	0.000632	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CD28—multiple sclerosis	0.00016	0.000632	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.000158	0.000623	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR2—multiple sclerosis	0.000157	0.00062	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—S1PR1—multiple sclerosis	0.000156	0.000617	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2RA—multiple sclerosis	0.000154	0.000609	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTGER4—multiple sclerosis	0.000154	0.000608	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-A—multiple sclerosis	0.000152	0.000602	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCR3—multiple sclerosis	0.000149	0.000587	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TLR4—multiple sclerosis	0.000147	0.000583	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HLA-DRB1—multiple sclerosis	0.000147	0.000582	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RGS1—multiple sclerosis	0.000146	0.000578	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CNR1—multiple sclerosis	0.000145	0.000572	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR2—multiple sclerosis	0.000145	0.000571	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000143	0.000564	CbGpPWpGaD
Olopatadine—S100A12—Immune System—ICAM1—multiple sclerosis	0.000141	0.000559	CbGpPWpGaD
Olopatadine—S100B—Immune System—TLR4—multiple sclerosis	0.000139	0.000551	CbGpPWpGaD
Olopatadine—S100B—Immune System—HLA-DRB1—multiple sclerosis	0.000139	0.00055	CbGpPWpGaD
Olopatadine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000139	0.00055	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GPR65—multiple sclerosis	0.000139	0.000548	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD80—multiple sclerosis	0.000136	0.000538	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000136	0.000537	CbGpPWpGaD
Olopatadine—S100B—Immune System—ICAM1—multiple sclerosis	0.000134	0.000528	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CNR1—multiple sclerosis	0.000133	0.000527	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RGS1—multiple sclerosis	0.000133	0.000525	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL10—multiple sclerosis	0.00013	0.000515	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD80—multiple sclerosis	0.000129	0.000508	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR1—multiple sclerosis	0.000127	0.000501	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000127	0.000501	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GPR65—multiple sclerosis	0.000126	0.000497	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK1—multiple sclerosis	0.000126	0.000496	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000122	0.000483	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LINGO1—multiple sclerosis	0.000122	0.000481	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL10—multiple sclerosis	0.00012	0.000475	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK1—multiple sclerosis	0.000119	0.000469	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR1—multiple sclerosis	0.000115	0.000455	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL13—multiple sclerosis	0.000115	0.000455	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TYK2—multiple sclerosis	0.000115	0.000454	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000115	0.000453	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CD86—multiple sclerosis	0.000114	0.000451	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000113	0.000446	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL5—multiple sclerosis	0.000112	0.000444	CbGpPWpGaD
Olopatadine—S100B—Immune System—TYK2—multiple sclerosis	0.000109	0.000429	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IFNG—multiple sclerosis	0.000108	0.000425	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TAGAP—multiple sclerosis	0.000106	0.000417	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SPP1—multiple sclerosis	0.000104	0.000411	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CD4—multiple sclerosis	0.000104	0.00041	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL5—multiple sclerosis	0.000103	0.000409	CbGpPWpGaD
Olopatadine—S100B—Immune System—IFNG—multiple sclerosis	0.000102	0.000402	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—multiple sclerosis	0.000101	0.0004	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2RA—multiple sclerosis	9.97e-05	0.000394	CbGpPWpGaD
Olopatadine—S100B—Immune System—CD4—multiple sclerosis	9.82e-05	0.000388	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—multiple sclerosis	9.65e-05	0.000381	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—multiple sclerosis	9.6e-05	0.000379	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	9.56e-05	0.000378	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL2—multiple sclerosis	9.56e-05	0.000378	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	9.36e-05	0.00037	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—multiple sclerosis	9.32e-05	0.000368	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—S1PR1—multiple sclerosis	9.23e-05	0.000365	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—multiple sclerosis	9.2e-05	0.000364	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—multiple sclerosis	9.12e-05	0.00036	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—multiple sclerosis	9.07e-05	0.000358	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL2—multiple sclerosis	9.04e-05	0.000357	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GPC5—multiple sclerosis	8.98e-05	0.000355	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTGER4—multiple sclerosis	8.7e-05	0.000344	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCR3—multiple sclerosis	8.4e-05	0.000332	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CD80—multiple sclerosis	8.32e-05	0.000329	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL3—multiple sclerosis	8.21e-05	0.000324	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR2—multiple sclerosis	8.17e-05	0.000323	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—multiple sclerosis	8.04e-05	0.000318	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—POMC—multiple sclerosis	7.91e-05	0.000312	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTGER4—multiple sclerosis	7.9e-05	0.000312	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RGS1—multiple sclerosis	7.85e-05	0.00031	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—multiple sclerosis	7.73e-05	0.000306	CbGpPWpGaD
Olopatadine—Acepromazine—ALB—multiple sclerosis	7.7e-05	0.251	CrCbGaD
Olopatadine—HRH1—Signaling by GPCR—CXCR3—multiple sclerosis	7.63e-05	0.000301	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—multiple sclerosis	7.61e-05	0.000301	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CNR1—multiple sclerosis	7.54e-05	0.000298	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GPR65—multiple sclerosis	7.44e-05	0.000294	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR2—multiple sclerosis	7.42e-05	0.000293	CbGpPWpGaD
Olopatadine—Thiothixene—ALB—multiple sclerosis	7.41e-05	0.242	CrCbGaD
Olopatadine—S100A12—Immune System—MAPK1—multiple sclerosis	7.31e-05	0.000289	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	7.3e-05	0.000289	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—POMC—multiple sclerosis	7.28e-05	0.000288	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—multiple sclerosis	7.13e-05	0.000282	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TYK2—multiple sclerosis	7.02e-05	0.000277	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK1—multiple sclerosis	6.91e-05	0.000273	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CNR1—multiple sclerosis	6.85e-05	0.000271	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR1—multiple sclerosis	6.8e-05	0.000269	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL13—multiple sclerosis	6.8e-05	0.000269	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL10—multiple sclerosis	6.79e-05	0.000268	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SRM—multiple sclerosis	6.47e-05	0.000256	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL10—multiple sclerosis	6.17e-05	0.000244	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6e-05	0.000237	CbGpPWpGaD
Olopatadine—Clomipramine—ALB—multiple sclerosis	5.86e-05	0.191	CrCbGaD
Olopatadine—HRH1—GPCR downstream signaling—CCL5—multiple sclerosis	5.85e-05	0.000231	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL2—multiple sclerosis	5.84e-05	0.000231	CbGpPWpGaD
Olopatadine—Nortriptyline—ALB—multiple sclerosis	5.72e-05	0.187	CrCbGaD
Olopatadine—S100A12—Immune System—IL6—multiple sclerosis	5.62e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	5.61e-05	0.000222	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—multiple sclerosis	5.53e-05	0.000219	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—multiple sclerosis	5.31e-05	0.00021	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL5—multiple sclerosis	5.31e-05	0.00021	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—multiple sclerosis	5.27e-05	0.000208	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2RA—multiple sclerosis	5.19e-05	0.000205	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—multiple sclerosis	4.92e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL3—multiple sclerosis	4.85e-05	0.000192	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—multiple sclerosis	4.78e-05	0.000189	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2RA—multiple sclerosis	4.71e-05	0.000186	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTGER4—multiple sclerosis	4.67e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PGR—multiple sclerosis	4.6e-05	0.000182	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—multiple sclerosis	4.57e-05	0.000181	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.56e-05	0.00018	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.56e-05	0.00018	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—multiple sclerosis	4.56e-05	0.00018	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCR3—multiple sclerosis	4.51e-05	0.000178	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK1—multiple sclerosis	4.47e-05	0.000177	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CD28—multiple sclerosis	4.46e-05	0.000176	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR2—multiple sclerosis	4.38e-05	0.000173	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.17e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—POMC—multiple sclerosis	4.12e-05	0.000163	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR1—multiple sclerosis	4.05e-05	0.00016	CbGpPWpGaD
Olopatadine—Amitriptyline—ALB—multiple sclerosis	3.97e-05	0.13	CrCbGaD
Olopatadine—HRH1—Signaling by GPCR—POMC—multiple sclerosis	3.74e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—multiple sclerosis	3.66e-05	0.000144	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL10—multiple sclerosis	3.64e-05	0.000144	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.46e-05	0.000137	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—multiple sclerosis	3.44e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TYK2—multiple sclerosis	3.32e-05	0.000131	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CD86—multiple sclerosis	3.19e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL5—multiple sclerosis	3.14e-05	0.000124	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IL2—multiple sclerosis	3.04e-05	0.00012	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SPP1—multiple sclerosis	2.9e-05	0.000115	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—multiple sclerosis	2.82e-05	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2RA—multiple sclerosis	2.78e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL2—multiple sclerosis	2.76e-05	0.000109	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—multiple sclerosis	2.57e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CD80—multiple sclerosis	2.32e-05	9.18e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—POMC—multiple sclerosis	2.21e-05	8.72e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—multiple sclerosis	2.16e-05	8.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MAPK1—multiple sclerosis	2.11e-05	8.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.98e-05	7.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TYK2—multiple sclerosis	1.96e-05	7.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL2—multiple sclerosis	1.63e-05	6.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—multiple sclerosis	1.62e-05	6.42e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—multiple sclerosis	1.54e-05	6.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—multiple sclerosis	1.37e-05	5.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—multiple sclerosis	1.28e-05	5.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—multiple sclerosis	1.27e-05	5.03e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK1—multiple sclerosis	1.25e-05	4.93e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—multiple sclerosis	1.19e-05	4.72e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.03e-05	4.05e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—multiple sclerosis	9.59e-06	3.79e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—multiple sclerosis	9.35e-06	3.69e-05	CbGpPWpGaD
